3D Tissue Models
The 4th Asia-Australia Congress on Controversies in Opthalmology (COPHY AA)
SHANGRI-LA AT THE FORT
30th Street corner 5th Avenue Bonifacio Global City
Manila, Philippines
http://www.comtecmed.com/cophy/aa/2018/
The 4th Asia-Australia Congress on Controversies in Opthalmology (COPHY AA)
Comtec Med
http://www.comtecmed.com/cophy/aa/2018/
SHANGRI-LA AT THE FORT
30th Street corner 5th Avenue Bonifacio Global City
Manila
Philippines

Schedule of Presentations:

Thursday, February 1, 2018
06:00:00 New Presentation
06:00:00 New Presentation
06:00:00 New Presentation
Friday, February 2, 2018
07:30:00 Breakfast Session | Hot Controversies in Retina: A Vision Academy Perspective Taiji Sakamoto, Neil Bressler
07:40:00 Debate I: Use of topical antibiotics with intravitreal injections Paisan Ruamviboonsuk, Anat LOEWENSTEIN
08:00:00 Debate II: Optimal treatment regimen with anti-VEGF Adrian KOH, Anat LOEWENSTEIN
08:20:00 Looking forward with the Vision Academy Taiji Sakamoto, Anat LOEWENSTEIN
08:30:00 OPENING SESSION | Big Controversies in Ophthalmology in 2018 Neil Bressler
08:30:00 Debate I: Proliferative diabetic retinopathy: Anti VEGF without PRP is an acceptable first step Paisan RUAMVIBOONSUK
09:00:00 Debate II: Wide-field imaging typically should be obtained in diabetic retinopathy Jeffrey Lim
09:30:00 Debate III: Neuro-protection in glaucoma: A viable pursuit Christopher Leung
10:00:00 Visit to Exhibits - Coffee and Refreshment Break
10:30:00 RETINA I | Non-neovascular ( Neil Bressler
10:30:00 Debate I: Monitor geographic atrophy with autofluorescence Thanapong Somkijrungroj, Adrian KOH
11:00:00 Debate II: Patients with large drusen should be encouraged to eat diets with more green leafy vegetables and omega-3 fatty acids than in a standard diet
11:30:00 Debate III: Targeting the alternative complement pathway in geographic atrophy still should be pursued Gemmy CHEUNG
12:00:00 Visit to Exhibits & Technical Break
12:15:00 INDUSTRY-SPONSORED LUNCHEON SYMPOSIUM (NOT FOR CME) (Lunchbox served in hall 12:15-12:30)
13:30:00 Visit to Exhibits - Dessert Break Anat LOEWENSTEIN
14:00:00 RETINA II | Diabetic Macular Edema Anat LOEWENSTEIN
14:00:00 Debate I: Switch from anti-VEGF to corticosteroids in phakic patients with DME and inadequate response
14:30:00 Debate II: Clinically significant DME without abnormal central subfield thickness should be treated with macular laser Sherman VALERO
15:00:00 Debate III: Treat symptomatic center-involved DME with 20/20 vision using anti-VEGF instead of macular laser or observation alone Gemmy CHEUNG
15:30:00 Debate I: Non-clearing vitreous hemorrhage in PDR: Try a series of anti-VEGF injections before going to vitrectomy Taiji Sakamoto, Susan Bressler
15:30:00 RETINA III| Retinal Detachment and Vitrectomy Taiji Sakamoto, Joseph Moisseiev
16:00:00 Debate II: Vitrectomy alone is superior to a scleral buckle for a total RD with small tear at 1 o'clock in a phakic 40-year old eye Joseph Moisseiev, Taiji SAKAMOTO
16:30:00 Debate III: Large, thick, subretinal hemorrhage from PCV in AMD should be treated initially with anti-VEGF rather than vitrectomy with tPA William Mieler
Saturday, February 3, 2018
06:00:00 New Presentation
06:00:00 New Presentation
06:00:00 New Presentation
06:00:00 New Presentation
06:00:00 New Presentation
06:00:00 New Presentation
06:00:00 New Presentation
06:00:00 New Presentation
08:30:00 RETINA IV | Polypoidal Vasculopathy (PCV) Paolo Antonio Silva, Arvind Kohli
08:30:00 Debate I: ICG typically is needed to diagnose PCV Voraporn Chaikitmongkol
09:00:00 Debate II: PCV: EVEREST approach (Initiate Anti-VEGF and PDT) over PLANET approach Paisan Ruamviboonsuk, Adrian KOH
09:30:00 Debate III: OCTA is helpful in the management of PCV Shwu-Jiuan Sheu, Voraporn Chaikitmongkol
10:00:00 Visit to Exhibits - Coffee and Refreshment Break
10:30:00 RETINA V | Pathologic Myopia and Central Serous Retinopathy Micahella Goldstein
10:30:00 Debate I: Reduce children’s time indoors to reduce incidence of pathologic myopia Pei-Chung Wu
11:00:00 Debate II: When treating chronic CSR, use verteporfin PDT rather than laser, antiVEGF, or oral medication Joseph Moisseiev
11:30:00 Debate III: Myopic foveoschisis should be treated by vitrectomy William Mieler
12:00:00 Visit to Exhibits - Technical Break
12:15:00 INDUSTRY-SPONSORED LUNCHEON SYMPOSIUM (NOT FOR CME) (Lunchbox served in hall 12:15-12:30)
13:30:00 Visit to Exhibits - Dessert Break
14:00:00 Debate I: Switch from anti-VEGF to corticosteroids in phakic patients with DME and inadequate response Pei-Chung Wu
14:00:00 RETINA II | Diabetic Macular Edema
14:30:00 Debate II: Clinically significant DME without abnormal central subfield thickness should be treated with macular laser Sherman VALERO
15:00:00 Debate III: Treat symptomatic center-involved DME with 20/20 vision using anti-VEGF instead of macular laser or observation alone Gemmy Cheung
15:30:00 Debate I: Non-clearing vitreous hemorrhage in PDR: Try a series of anti-VEGF injections before going to vitrectomy Taiji Sakamoto, Susan Bressler
15:30:00 RETINA III| Retinal Detachment and Vitrectomy Taiji Sakamoto, Joseph Moisseiev
16:00:00 Debate II: Vitrectomy alone is superior to a scleral buckle for a total RD with small tear at 1 o'clock in a phakic 40-year old eye Joseph Moisseiev, Taiji Sakamoto
16:30:00 Debate III: Large, thick, subretinal hemorrhage from PCV in AMD should be treated initially with anti-VEGF rather than vitrectomy with tPA William Mieler
Sunday, February 4, 2018
About Us | Privacy Policy | Site Map | FAQs | Advertise With Us | Community
BiotechScienceNews.com promotes research and ranks life scientists working in the life science spectrum involving biotechnology,
drug discovery, genomics, microbiology, neuroscience, medicine, pharmacology, cell biology, and molecular biology.